NCT07322107Active, not recruiting
Prefrontal Brain Activity and ECG Patterns in Stroke and Healthy Adults
Observation of Prefrontal Cortex Activation and Electrocardiographic Characteristics in Stroke Patients and Healthy Adults
Source: ClinicalTrials.gov · Last updated 7 Jan 2026
Brief summary (registry, in English)
This observational study will evaluate brain activity and heart rhythm patterns in people with and without stroke. Brain activity will be measured using functional near-infrared spectroscopy (fNIRS) and electroencephalography (EEG), and cardiac activity will be measured using electrocardiography (ECG). The goal is to characterize differences in prefrontal brain activation and ECG features between stroke patients and healthy adults
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 45 (estimated)
- First submitted
- 23 Dec 2025
- Start date
- 6 Nov 2025
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Pusan National University Yangsan Hospital
- Diseases
- Stroke
- NCT number
- NCT07322107
What you commit to
- Study type: Observational
- Planned participants: 45
- From 6 Nov 2025 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Participants meeting any of the following exclusion criteria will not be enrolled in the study.
- History of head trauma or cranial surgery within the past 6 months with wounds that have not yet fully healed.
- Current diagnosis of a severe psychiatric disorder, such as schizophrenia, major depressive disorder, or bipolar disorder.
- Participation in another clinical study and intake of an investigational drug within the past 30 days.
- Women who are pregnant or breastfeeding.
- Presence of an acute infection or inflammatory disease.
- Inability to adequately understand the study procedures or lack of voluntary consent to participate.
- Any other clinically significant finding that, in the judgment of the principal investigator or designated study physician, makes the individual unsuitable for participation in this study.
Who the study is looking for
- Intracerebral Hemorrhage Group (Stroke Patients)
- Adults aged 19 to 80 years.
- Diagnosed with intracerebral hemorrhage based on clinical evaluation and neuroimaging findings.
- Able to read and understand the participant information sheet and consent form, and capable of completing questionnaires in the study language.
- Voluntarily agrees to participate in the study, provides written informed consent, and is able to participate for the entire study period.
- Cerebral Infarction Group (Stroke Patients)
- Adults aged 19 to 80 years.
- Diagnosed with cerebral infarction (ischemic stroke) based on clinical evaluation and neuroimaging findings.
- Able to read and understand the participant information sheet and consent form, and capable of completing questionnaires in the study language.
- Voluntarily agrees to participate in the study, provides written informed consent, and is able to participate for the entire study period.
- Healthy Adult Group
- Adults aged 19 to 80 years.
- No history of stroke or transient ischemic attack (TIA).
- No major stroke risk factors such as hypertension, diabetes mellitus, or hyperlipidemia.
- No chronic diseases, including cardiovascular disease, chronic kidney disease, or chronic pulmonary disease.
- No psychiatric disorders, such as depression or schizophrenia.
- Not taking medications that may affect cerebral hemodynamics, including antihypertensive agents, anticoagulants, antiplatelet agents, or antidepressants.
- Able to read and understand the participant information sheet and consent form, and capable of completing questionnaires in the study language.
- Voluntarily agrees to participate in the study, provides written informed consent, and is able to participate for the entire study period.
Age in the registry: 19 years to 80 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Rehab lab, Pusan National University Yangsan Hospital Coordinator of this site? Confirm its status | Yangsan | South Korea | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.